Very Early and Early Onset Schizophrenia: Clinical characteristics and implications for interventions

Author/s Maria Pontillo, Marco Armando, Milena Coletti, Ornella Santonastaso, Stefano Vicari
Publishing Year 2016 Issue 2016/39 Language Italian
Pages 17 P. 25-41 File size 115 KB
DOI 10.3280/QPC2016-039003
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

Very Early (VEOS) and Early Onset Schizophrenia (EOS) represent more severe forms of the disorder, with clear differences from Adult Onset Schizophrenia (AOS). Indeed, VEOS/EOS, compared to AOS, show higher rates of premorbid abnormalities, longer duration of untreated psychosis, and poorer outcomes. Moreover, higher levels of auditory hallucinations, negative symptoms, bizarre behavior and more severe cognitive deficits characterize VEOS/EOS. In addition, because the onset of the disorder occurs during a critical developmental period, individuals with VEOS/EOS are restricted in the attainment of developmental and social milestones. They are subsequently subjected to additional interruptions in education, employment, and peer relationships, which further complicated recovery. Overall, because individuals with VEOS/EOS have specific developmental issues that are very different from those of individuals with AOS, better-designed interventions that are tailored to this age group and account for their developmental differences are needed.

Keywords: Early onset schizophrenia, Clinical Staging Model, cognitive-behavioral therapy

  1. Agius M., Goh C., Ulhaq S., McGorry P. (2010). The staging model in schizophrenia, and its clinical implications. Psychiatria Danubina, 22(2): 211-220.
  2. Arango C., Rapado-Castro M., Reig S., Castro-Fornieles J., Gonzalez-Pinto A., Otero S., Baeza I., Moreno C., Graell M., Janssen J., Parellada M., Moreno D., Bargallo N., Desco M. (2012). Progressive brain changes in children and adolescents with first-episode psychosis. Archives of General Psychiatry, 69(1): 16-26.
  3. Armando M., Pontillo M., De Crescenzo F., Mazzone L., Lo Cascio N., Santonastaso O., Pucciarini M., Vicari S., Schimmelmann B., Schultze-Lutter F. (2015). Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents. Schizophrenia Research, 169: 186-192.
  4. Birchwood M., Macmillan F. (1993). Early intervention in schizophrenia. Australian and New Zealand Journal of Psychiatry, 27(3): 374-378. DOI: 10.3109/0004867930907579
  5. Bleuler E. (1926). La Schizophrénie. Congrès des Médecins Aliénistes et Neurologistes de France et des Pays de langue Française. XXX session. Geneve-Lausanne-Paris: Masson, pp. 1-24.
  6. Brown G.W., Birley J.L., Wing J.K. (1972). Influence of family life on the course of schizophrenic disorders: a replication. British Journal of Psychiatry, 121(562): 241-258.
  7. Bryce S., Sloan E., Lee S., Ponsford J., Rossell S.J. (2016). Cognitive remediation in schizophrenia: A methodological appraisal of systematic reviews and meta-analyses. Journal of Psychiatric Research, 75: 91-106.
  8. Davis J., Eyre H., Jacka F.N., Dodd S., Dean O., McEwen S., Debnath M., McGrath J., Maes M., Amminger P., McGorry P.D., Pantelis C., Berk M. (2016). A Review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. Neuroscience and Biobehavioral Reviews, 65: 185-194.
  9. Donogue K., Doody G.A., Murray R.M., Jones P.B., Morgan C., Dazzan P., Hart J., Mazzoncini R., Maccabe J.H. (2014). Cannabis use, gender and age of onset of schizophrenia: data from the AESOP study. Psychiatry Research, 215(3): 528-532.
  10. Fiori Nastro P., Schimmelmann B.G., Gebhardt E., Monducci E., Resch F., Koch E., Scultze-Lutter F. (2012). Le sfide per una corretta individuazione precoce delle psicosi nei bambini e negli adolescenti. Challenges in the early detection of psychosis in children and adolescents. Rivista di Psichiatria, 47(2): 116-125. DOI: 10.1708/1069.1171
  11. Friis S., Melle I., Johannessen J.O., Rossberg J.I., Barder H.E., Evensen J.H., Haahr U.,Ten Velden Hegelstad W., Joa I., Langeveld J., Larsen T.K., Opjordsmoen S., Rund B.R., Simonsen E., Vaglum P.W., McGlashan T.H. (2015). Early Predictors of Ten-Year Course in First-Episode Psychosis. Psychiatric Services, 67(4): 438-443.
  12. Gage S.H., Munafo M.R. (2015). Smoking as a casual risk factor for schizophrenia. Lancet Psychiatry, 2(9): 778-779. DOI: 10.1016/S2215-0366(15)00333-
  13. Galletly C., Castle D., Dark F., Humberstone V., Jablensky A., Killackey E., Kulkarni J., McGorry P., Nielssen O., Tran N. (2016). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian & New Zealand Journal of Psychiatry, 50(5): 410-472. DOI: 10.1177/000486741664119
  14. Green M.F. (2016). Impact of Cognitive and Social Cognitive Impairment on Functional Outcomes in Patients With Schizophrenia. Journal of Clinical Psychiatry, 77, Suppl. 2: 8-11.
  15. Green M.J., Chia T.Y., Cairns M.J., Wu J., Tooney P.A., Scott R.J., Carr V.J., Australian Schizophrenia Research Bank (2014). Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia. Journal of Psychiatric Research, 49: 43-50.
  16. Guo X., Zhai J., Liu Z., Fang M., Wang B., Wang C., Hu B., Sun X., Lv L., Lu Z., Ma C., He X., Guo T., Xie S., Wu R., Xue Z., Chen J., Twamley E.W., Jin
  17. H., Zhao J. (2010). Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study. Archives of General Psychiatry, 67(9): 895-904.
  18. Hauser M., Juckel G. (2012). Psychoeducation in subjects at elevated risk for psychosis – Acritical review. Current Pharmaceutical Design, 18(4): 566-569. DOI: 10.2174/13816121279931612
  19. Kao Y.C., Liu Y.P. (2010). Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders. BMC Psychiatry, 10(63). DOI: 10.1186/1471-244X-10-6
  20. Kirkbride J.B., Fearon P., Morgan C., Dazzan P., Morgan K., Tarrant J., Lloyd T., Holloway J., Hutchinson G., Leff J.P., Mallett R.M., Harrison G.L., Murray R.M., Jones P.B. (2006). Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: Findings from the 3-center AeSOP study. Archives of General Psychiatry, 63(3): 250-258.
  21. Kirkbride J.B., Barker D., Cowden F., Stamps R., Yang M., Jones P.B., Coid J.W. (2008). Psychoses, ethnicity and socio-economic status. British Journal of Psychiatry, 193(1): 18-24.
  22. Kraepelin E. (1913). Dementia Praecox and Paraphrenia. Psychiatrie (8th edn), Band III, Teil 2, Kapitel 9 (trad. ing. Edinburgh: E. e S. Livingstone, 1919; Bristol: Thoemmes Press, 2002).
  23. Lenior M.E., Dingemans P.M., Linszen D.H., de Haan L., Schene A.H. (2001). Social functioning and the course of early-onset schizophrenia: five-year follow-up of a psychosocial intervention. British Journal of Psychiatry, 179(1): 53-58.
  24. Madaan V., Dvir Y., Wilson D.R. (2008). Child and adolescent schizophrenia: pharmacological approach. Expert Opinion on Pharmacotherapy, 9(12): 2053-2068. DOI: 10.1517/14656566.9.12.205
  25. McCann T.V., Lubman D.I., Clark E. (2011). First-time primary caregivers’ experience accessing first-episode psychosis services. Early Intervention in Psychiatry, 5(2): 156-162.
  26. McClennan J. (2005). Early Onset Schizophrenia. In: Sadock B.J., Sadock V.A., editors, Comprehensive Textbook of Psychiatry. 8th edition, vol. 2. Philadelphia: Lippincott Williams & Wilkins.
  27. McFarlane W.R. (2016). Family Interventions for Schizophrenia and the Psychoses: A Review. Family Process [Epub ahead of print].
  28. McGlashan T.H., Zipursky R.B., Perkins D., Addington J., Miller T., Woods S.W., Hawkins K.A., Hoffman R.E., Preda A., Epstein I., Addington D., Lindborg S., Trzaskoma Q., Tohen M., Breier A. (2006). Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry, 163 (5): 790-799.
  29. McGorry P.D. (2015). Early intervention in psychosis: obvious, effective, overdue. Journal of Nervous and Mental Disorders, 203(5): 310-318. DOI: 10.1097/NMD.000000000000028
  30. McGorry P.D., Nelson B., Goldstone S., Yung A.R. (2010). Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Canadian Journal of Psychiatry, 55(8): 486-497. DOI: 10.1177/07067437100550080
  31. McGrath J., Saha S., Chant D., Welham J. (2008). Schizophrenia: a concise overview of incidence, prevalence and mortality. Epidemiologic Reviews, 30: 67-76.
  32. Miyamoto S., Duncan G.E., Marx C.E., Lieberman J.A. (2005). Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Molecular Psychiatry, 10: 79-104.
  33. 4001556 Morrison A.P., Barratt S. (2010). What are the components of CBT for psychosis? A Delphi study. Schizophrenia Bulletin, 36(1): 136-142.
  34. Muller H., Laier S., Bechdolf A. (2014). Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis. European Archives of Psychiatry and Clinical Neuroscience, 264, Suppl. 1: 17-25.
  35. Murray R.M., Jones P.B., Susser E., van Os J., Cannon M., editors (2003). The Epidemiology of Schizophrenia. Cambridge: UK Cambridge University Press, pp. 317-342.
  36. Nelson B., Yuen H.P., Lin A., Wood S.J., McGorry P.D., Hartmann J.A., Yung A.R. (2016). Further examination of the reducing transition rate in ultra high risk for psychosis samples: The possible role of earlier intervention. Schizophrenia Research, 174(1-3): 43-49.
  37. Pharoah F., Mari J., Rathbone J., Wong W. (2010). Family intervention for schizophrenia. Cochrane Database of Systematic Reviews, (12): CD000088.
  38. Plomin R., DeFries J.C., Knopik V.S., Neiderhiser J.M. (2016). Top 10 Replicated Findings From Behavioral Genetics. Perspectives on Psychological Science, 11(1): 3-23. DOI: 10.1177/174569161561743
  39. Preti A., Cella M. (2010). Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophrenia Research, 123(1): 30-36.
  40. Raji T.K., Ismail Z., Mulsant B.H. (2009). Age of onset and cognition in schizophrenia: meta-analysis. British Journal of Psychiatry, 195(4): 286-293.
  41. Rapoport J.L., Gogtay N. (2011). Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder. International Journal of Developmental Neuroscience, 29(3): 251-258.
  42. Roick C., Heider D., Bebbington P.E., Angermeyer M.C., Azorin J.M., Brugha T.S., Kilian R., Johnson S., Toumi M., Kornfeld A. (2007). Burden on caregivers of people with schizophrenia: comparison between Germany and Britain. British Journal of Psychiatry, 190(4): 333-338.
  43. Rund B.R., Moe L., Sollien T., Fjell A., Borchgrevink T., Hallert M., Naess P.O. (1994). The Psychosis Project: outcome and cost-effectiveness of a psychoeducational treatment programme for schizophrenic adolescents. Acta Psychiatrica Scandinavica, 89(3): 211-218.
  44. Souaiby L.L., Gaillard R., Krebs M.O. (2016). Duration of untreated psychosis: A state-of-the-art review and critical analysis. Encephale, S0013-7006(16): 30067-7.
  45. Stentebjerg-Olesen M., Pagsberg A.K., Fink-Jensen A., Correll C.U., Jeppesen P. (2016). Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review Journal of Child and Adolescent Psychopharmacology, 26(5): 410-427.
  46. Thomas N., Rossell S., Farhall J., Shawyer F., Castle D. (2011). Cognitive behavioural therapy for auditory hallucinations: effectiveness and predictors of outcome in a specialist clinic. Behavioural and Cognitive Psychotherapy, 39(2): 129-138. DOI: 10.1017/S135246581000054
  47. van der Gaag M.L., Smit F., Bechdolf A., French P., Linszen D.H., Yung A.R., McGorry P., Cuijpers P. (2013). Preventing a first episode of psychosis: metaanalysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophrenia Research, 149(1-3): 56-62.
  48. van Os J., Kapur S. (2009). Schizophrenia. Lancet, 374(9690): 635-645. DOI: 10.1016/S0140-6736(09)60995-
  49. van Os J., Kenis G., Rutten B.P. (2010). The environment and schizophrenia. Nature, 468(7321): 203-212.
  50. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P. (2011). A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. American Journal of Psychiatry, 168(5): 472-485.
  51. Xia J., Merinder L.B., Belgamwar M.R. (2011). Psychoeducation for schizophrenia. Cochrane Database of Systematic Reviews, (6): CD002831.
  52. Yung A.R., Killackey E., Hetrick S.E., Parker A.G., Schultze-Lutter F., Klosterkoetter J., Purcell R., Mcgorry P.D. (2007). The prevention of schizophrenia. International Review of Psychiatry, 19: 633-646. DOI: 10.1080/0954026070179780

Maria Pontillo, Marco Armando, Milena Coletti, Ornella Santonastaso, Stefano Vicari, Schizofrenia ad esordio in età evolutiva: aspetti clinici e interventi possibili in "QUADERNI DI PSICOTERAPIA COGNITIVA" 39/2016, pp 25-41, DOI: 10.3280/QPC2016-039003